Is one young Georgia Tech company about to end complications from epidural misplacement? Read about their experience at T3 Labs.

“It is exceedingly rare for student medtech projects to become companies,” Rains said. “But in a very intentional way, and thanks to a robust local and regional medtech ecosystem, that is exactly what is happening here.” Among the approximately 4 million births in the United States each year, 2.4 million of those mothers elect to…

Industry leading speakers including GCMI, JPMorgan, AdvaMed, Halyard and more announced for SEMDA 2018

Earlier this week, the Southeastern Medical Device Association announced several industry leading plenary and keynote speakers set for next month’s 2018 SEMDA Annual Medtech Conference in Greenville, South Carolina. Representing GCMI, and its Design and Development line of service, our Product Development Director, Mike Fisher will serve on a panel led by Paul Snyder, VP of…

See you at SIR 2018, Booth 833

GCMI-T3 Labs will be exhibiting at the Society of Interventional Radiology annual meeting (Booth 833), which will be held March 17-22, 2018 in sunny Los Angeles, CA. This is a great opportunity to learn about the latest clinical and scientific contributions as well as current treatments, needs and future trends in interventional radiology. We look…

Time again to connect with orthopedic experts and expand our knowledge of musculoskeletal therapies at AAOS 2018!

  Connect with T3 Labs at AAOS 2018 The American Academy of Orthopaedic Surgeons’ Annual Meeting (AAOS) is the premier ortho event of the year: hosting thousands of thought leaders, physicians, scientists and academics seeking the latest in injury prevention and disease treatment of the musculoskeletal system. AAOS 2018 will bring the top names in…

GCMI 2017 Year In Review

We want to begin by wishing you and your team, a joyous and safe holiday season. Thank you for all your support and the opportunities you have sent our way.  We hope you all get to enjoy this time with your loved ones. In so many ways, 2017 was a landmark year for GCMI. From…

Supporting the development of new Point of Care (POC) technologies with IEEE and NIH

Michael Fisher, Director of Product Development for GCMI, shares his insights from the IEEE-NIH Healthcare Innovations and Point of Care Technology conference. Recently, GCMI attended and spearheaded a presentation during the IEEE-NIH Healthcare Innovations and Point of Care Technology conference which focuses on innovation and technologies for precision health and their clinical translation, to address…

Selecting the right preclinical partner: Why Cell Constructs utilizes T3 Labs as their trusted Preclinical CRO

For medical product innovators large and small, T3 Labs prides itself on delivering the highest value preclinical testing and bioskills training services available. Depending on the class and type of submission, not every medical product requires preclinical studies, however, completing preclinical studies is advantageous for proof of concept, when raising capital, applying for reimbursement, and…